PlainMeds research, FDA and CMS files of October 8, 2026
Medicines first approved since 2024
106 medicines on this site had their first FDA approval (an original NDA or BLA) on or after January 1, 2024; the newest is Camizestrant (2026-09-04).
What the data shows
| Medicine | First approved | Brand | Sponsor |
|---|---|---|---|
| Camizestrant | 2026-09-04 | Etcamah | Astrazeneca |
| Rusfertide | 2026-08-28 | Mimrylo | Takeda Pharms Am |
| Bictegravir and lenacapavir | 2026-08-27 | Bixlenvo | Gilead Sciences Inc |
| Brepocitinib | 2026-08-27 | Lisraya | Priovant Therap |
| Daraxonrasib | 2026-08-26 | Rasonque | Revolution Medicines |
| Iberdomide | 2026-08-13 | Zenbexus | Bristol Myers Squibb |
| Zidesamtinib | 2026-07-22 | Jideytro | Nuvalent |
| Enlicitide | 2026-07-15 | Lipfendra | Msd |
| Gedatolisib | 2026-07-14 | Revtorpyk | Celcuity |
| Gadoquatrane | 2026-06-12 | Ambelvist | Bayer Healthcare |
| Cefepime and zidebactam | 2026-05-29 | Zaynich | Wockhardt Bio Ag |
| Ensitrelvir | 2026-05-29 | Xocova | Shionogi |
| Baxdrostat | 2026-05-15 | Baxfendy | Astrazeneca Ab |
| Sonrotoclax | 2026-05-13 | Beqalzi | Beone Medicines Usa |
| Vepdegestrant | 2026-05-01 | Veppanu | Rigel Pharms |
| Doravirine and islatravir | 2026-04-20 | Idvynso | Msd |
| Orforglipron | 2026-04-01 | Foundayo | Eli Lilly And Co |
| Relacorilant | 2026-03-25 | Lifyorli (Copackaged) | Corcept Therap |
| Icotrokinra | 2026-03-17 | Icotyde | Janssen Biotech |
| Linerixibat | 2026-03-17 | Lynavoy | Intercept |
| Navepegritide | 2026-02-27 | Yuviwel | Ascendis |
| Milsaperidone | 2026-02-20 | Bysanti | Vanda Pharms Inc |
| Difamilast | 2026-02-12 | Adquey | Acrotech Biopharma |
| Air | 2026-02-02 | Air | General Air Service & Supply Company |
| Brimonidine and carbachol | 2026-01-28 | Yuvezzi | Visus |
| Copper histidinate | 2026-01-12 | Zycubo | Sentynl Theraps Inc |
| Tradipitant | 2025-12-30 | Nereus | Vanda Pharms Inc |
| Dextromethorphan and guaifenesin and naproxen | 2025-12-22 | Mucinex 12Hr Cold & Fever Multi-Symptom | Reckitt Benckiser |
| Aficamten | 2025-12-19 | Myqorzo | Cytokinetics |
| Etripamil | 2025-12-12 | Cardamyst | Milestone Pharms Usa |
| Zoliflodacin | 2025-12-12 | Nuzolvence | Entasis Therap |
| Sevabertinib | 2025-11-19 | Hyrnuo | Bayer Healthcare |
| Plozasiran | 2025-11-18 | Redemplo | Arrowhead |
| Ziftomenib | 2025-11-13 | Komzifti | Kura |
| Doxecitine and doxribtimine | 2025-11-03 | Kygevvi | Ucb Inc |
| Elinzanetant | 2025-10-24 | Lynkuet | Bayer Hlthcare |
| Nerandomilast | 2025-10-07 | Jascayd | Boehringer Ingelheim |
| Remibrutinib | 2025-09-30 | Rhapsido | Novartis |
| Imlunestrant | 2025-09-25 | Inluriyo | Eli Lilly And Co |
| Paltusotine | 2025-09-25 | Palsonify | Crinetics |
| Elamipretide | 2025-09-19 | Forzinity | Stealth Biotheraps |
| Rilzabrutinib | 2025-08-29 | Wayrilz | Genzyme Corp |
| Donidalorsen | 2025-08-21 | Dawnzera (Autoinjector) | Ionis Pharms Inc |
| Brensocatib | 2025-08-12 | Brinsupri | Insmed Inc |
| Zongertinib | 2025-08-08 | Hernexeos | Boehringer Ingelheim |
| Dordaviprone | 2025-08-06 | Modeyso | Chimerix |
| Aceclidine | 2025-07-31 | Vizz | Lenz Therap |
| Concizumab | 2025-07-31 | Alhemo | Novo Nordisk Inc |
| Sepiapterin | 2025-07-28 | Sephience | Ptc Therap |
| Delgocitinib | 2025-07-23 | Anzupgo | Leo Pharma As |
| Sebetralstat | 2025-07-03 | Ekterly | Kalvista |
| Taletrectinib adipate | 2025-06-11 | Ibtrozi | Nuvation |
| Amlodipine and indapamide and telmisartan | 2025-06-05 | Widaplik | Azurity |
| Acoltremon | 2025-05-28 | Tryptyr | Alcon Labs Inc |
| Avutometinib and defactinib | 2025-05-08 | Avmapki Fakzynja Co-Pack (Copackaged) | Verastem Inc |
| Atrasentan | 2025-04-02 | Vanrafia | Novartis |
| Fitusiran | 2025-03-28 | Qfitlia | Genzyme Corp |
| Gepotidacin | 2025-03-25 | Blujepa | Glaxosmithkline |
| Vimseltinib | 2025-02-14 | Romvimza | Deciphera Pharms |
| Mirdametinib | 2025-02-11 | Gomekli | Springworks |
The table shows the first 60 of 106 rows.
Source: Drugs@FDA and the FDA NDC Directory, read October 8, 2026
How it was measured
Drugs@FDA original submissions with approval status, the earliest NDA or BLA per medicine; only medicines listed in the NDC Directory are on this site.
What it cannot show
A new salt, form or combination of an older medicine is a separate medicine here; vaccines and blood products outside the NDC finished-drug list are not counted.